期刊文献+

猪干扰素γ的原核表达及抗血清的制备 被引量:2

Prokaryotic Expression of Porcine Interferon γ and Preparation of Antisera
原文传递
导出
摘要 目的原核表达猪干扰素γ(poIFNγ),并制备其抗血清。方法PCR扩增poIFNγ成熟多肽基因片段,克隆至原核表达载体pET-28a(+)中,构建重组表达质粒pET-28a-poIFNγ,转化大肠杆菌BL21(DE3),IPTG诱导表达。表达的蛋白纯化后免疫小鼠,制备抗血清,ELISA检测抗血清的效价。结果重组原核表达质粒pET-28a-poIFNγ经双酶切和测序证明构建正确;重组蛋白的表达量占菌体总蛋白的40%,主要以包涵体形式表达;纯化的重组蛋白纯度可达90%;制备的抗血清效价可达10-5。结论已成功地在大肠杆菌中表达了poIFNγ,并制备了较高效价的抗血清。 Objective To express porcine interferon γ(poIFNγ)in prokaryotic cells and prepare the antisera. Methods The gene fragment encoding mature polypeptide of poIFNγ was amplified by PCR and cloned into prokaryotic expression vector pET28a(+). The constructed recombinant plasmid pET-28a-poIFNγ was transformed to E. coli BL21(DE3)for expression under induction of IPTG. The expressed protein was purified and inoculated to mice, and the antisera were prepared and determined for titer by ELISA. Results Both restriction analysis and sequencing proved that recombinant plasmid pET-28a-poIFNγ was constructed correctly. The expressed product, mainly existing in a form of inclusion body, contained 40% of total somatic protein and reached a purity of 90% after purification. The titer of prepared antisera was 10-5. Conclusion Porcine interferon γ was successfully expressed in E. coli, and high titer antisera was prepared.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第4期416-418,424,共4页 Chinese Journal of Biologicals
关键词 猪干扰素γ 原核表达 抗血清 Porcine interferon γ(poIFNγ) Prokaryotic expression Antisera
  • 相关文献

参考文献12

  • 1陈慰峰.医学免疫学.3版.北京:人民卫生出版社,2001:46.
  • 2Koch M, Witzenrath M, Reuter C, et al. Role of local pulmonary IFN-gamma expression in murine allergic airway inflammation. Am J Respir Cell Mol Biol, 2006, 35 (2): 211-219.
  • 3Gollob JA, Seiambi CJ. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal Melanoma cells . Clin Cancer Res, 2007, 13 (9): 5219-5225.
  • 4Carlo-Stella C, Guidetti A, Di Nicola M, et al. IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3. Cancer Res, 2007, 67 (7): 3269-3275.
  • 5Cantin E, Tanamachi B, Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reaction. J Virol, 1999, 73 (4): 3418-3423.
  • 6Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma an overview of signals, mechanisms and functions. J Leukocyte Biol, 2004, 75 (2):163-189.
  • 7Gonzalez-Juarrero M, Mebus C, Garmendia AE. Porcine lymphocyte gamma interferon responses to mitogenic stimuli monitored by a direct immunoassay. Vet Immunol Immunopathol, 1994, 40 ( 3 ): 201 -212.
  • 8Hu Y, Tan R, MacCalman CD, et al. IFN-gamma mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod, 2008, 14 (5): 281-289.
  • 9George J, Banik NL, Ray SK. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res, 2009, 15 (23): 7186- 7195.
  • 10Katayama A, Ogino T, Bandoh N, et al. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Clin Cancer Res, 2005, II (8): 2937-2946.

二级参考文献16

  • 1王盈,张晓燕,魏丽丽,吴东来,王晓钧,相文华,沈荣显,邵一鸣.EIAV减毒疫苗免疫后马外周血单个核细胞中IFN-γ的转录[J].细胞与分子免疫学杂志,2006,22(4):436-439. 被引量:4
  • 2Billiau A. Interferon: the pathways of discovery I. Molecular and cellular aspects. Cytokine & growth factor reviews, 2006, 17 (5): 381-409.
  • 3Letsch A, Seheibenbogen C. Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining. Methods, 2003, 31(2): 143-149.
  • 4Jung T, Schauer U, Heusser C, et al. Detection of intracellular cytokines by flow cytometry. J Immunol Methods, 1993, 159(1): 197-207.
  • 5Hinkula J, Rosen J, Sundqvist VA, et al. Epitope mapping of the HIV-1 gag region with monoclonal antibodies. Molecular Immunol, 1990, 27(5 ): 395-403.
  • 6Seligman SJ. Serial deletion mapping by competition ELISA assay: characterization of a linear epitope in the V3 loop of HIV-1. AIDS Res Hum Retroviruses, 1994, 10(2): 149-156.
  • 7Chen Y, Xiong X, Liu X, et al. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Molecular Immunol, 2006, 43(5): 436-442.
  • 8Liu W, Zou P, Chen YH. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunology Lett, 2004, 93(2): 131-136.
  • 9Curran JA, Argyle D J, Cox P, ct al. Nucleotide sequence of the equine interferon gamma cDNA. DNA Seq, 1994, 4i6): 405-407.
  • 10Steinbach F, Mauel S, Beier I. Recombinant equine interferons: expression cloning and biological activity. Veter Immunol Immunopathol, 2002, 84( 1 ): 83-95.

共引文献1

同被引文献48

  • 1侯相山,王洪水.干扰素研究进展[J].安徽农业科学,2007,35(6):1700-1702. 被引量:9
  • 2王云龙,李玲玲,李晨阳,吴阳.猪γ干扰素基因的合成、表达及纯化[J].中国生物制品学杂志,2007,20(7):511-514. 被引量:4
  • 3Schroder K, Hertzog PJ, Ravasi T, et ol. Interferon-gamma: an overview of signals, mechanisms and functions [J]. J Leukoc Biol, 2004, 75 (2): 163-189.
  • 4Groettrup M, Khan S, Schwarz K, et al. Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why [J]. Biochimie, 2001, 83 (34): 367-372.
  • 5Decker T, Stockinger S, Karaghiosoff M, et al. IFNs and STATs in innate immunity to microorganisms [J]: J Clin Invest, 2002, 109 (10): 1271-1277.
  • 6Waldburger JM, Masternak K, Muhlethaler-Mottet A, et al. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class lI expression [J]. Immunol Rev, 2000, 178: 148- 165.
  • 7Ferris RL, Whiteside TL, Ferrone S. Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer [J]. Clin Cancer Res, 2006, 12 ( 13): 3890-3895.
  • 8Del Vecchio M, Bajetta E, Canova S, et al. lnterleukin-12: biological properties and clinical application [J]. Clin Cancer Res, 2007, 13 ( 16): 4677-4685.
  • 9Malathi K, Paranjape JM, Bulanova E, etal. A transcriptional signaling pathway in the 1FN system mediated by 2'-5'-oligoadenylate activation of RNase L [J]. Proc Natl Acad Sci USA, 2005, 102(41 ): 14533-14538.
  • 10Das S, Ward SV, Tacke RS, et ol. Activation of the RNA-dependent protein Kinase PKR promoter in the absence of interferon is depen- dent upon Sp proteins [J]. J Biol Chem, 2006, 281(6): 3244-3253.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部